AI Assistant
Blog
Pricing
Log In
Sign Up
Typ-2-Diabetes: Frühzeitig auf Dreierkombination setzen? – Studie prüft komplementäre Therapie mit Dapagliflozin
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
